BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: 池肇春. 非酒精性脂肪性肝病发病机制研究进展与现状. 世界华人消化杂志 2017; 25(8): 670-683 [DOI: 10.11569/wcjd.v25.i8.670]
URL: https://www.wjgnet.com/1007-9327/full/v25/i8/670.htm
Number Citing Articles
1
Xingnan Wang, Yaopeng Ren, Shiqi Li, Chunfeng Guo, Zhenpeng Gao. Development of a polyphenol‐enriched whole kiwifruit dietary supplement and its potential in ameliorating hyperlipidemiaJournal of the Science of Food and Agriculture 2024; 104(4): 2142 doi: 10.1002/jsfa.13099
2
Ya‐jie Pan, Xing Ren, Ying‐ying Zhang, Jun Lv, Qing‐lei Zeng, Hong‐yu Zhang, Zu‐jiang Yu. IL‐17A‐mediated ERK1/2/p65 signaling pathway is associated with cell apoptosis after non‐alcoholic steatohepatitisIUBMB Life 2019; 71(3): 302 doi: 10.1002/iub.1960
3
Panli Tan, Li Jin, Xiang Qin, Beihui He. Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver diseaseFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1005312
4
Ruixi Luo, Yudie Hu, La Wang, Zunli Ke, Wenjia Wang, Ping Wang, Weiyi Tian. Penthorum chinense Pursh extract ameliorates hepatic steatosis by suppressing pyroptosis via the NLRP3/Caspase‐1/GSDMD pathwayFood Science & Nutrition 2024;  doi: 10.1002/fsn3.4165
5
Yong-Tian Zheng, Tian-Mei Xiao, Chan-Xian Wu, Jin-Yan Cheng, Le-Yu Li. Correlation of Adiponectin Gene Polymorphisms rs266729 and rs3774261 With Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.798417